Self‐Boosting Programmable Release of Multiple Therapeutic Agents by Activatable Heterodimeric Prodrug‐Enzyme Assembly for Antitumor Therapy
Abstract Endogenous stimuli‐responsive prodrugs, due to their disease lesion specificity and reduced systemic toxicity, have been widely explored for antitumor therapy. However, reactive oxygen species (ROS) as classical endogenous stimuli in the tumor microenvironment (TME) are not enough to achiev...
Saved in:
| Main Authors: | Shanshan Jiang, Bhaskar Gurram, Junfei Zhu, Shan Lei, Yifan Zhang, Ting He, Oya Tagit, Hui Fang, Peng Huang, Jing Lin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Advanced Science |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/advs.202409960 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A heterodimeric radioligand labeled with gallium-68 targeting fibroblast activation protein
by: Chengde Xie, et al.
Published: (2025-05-01) -
Creation of anthracycline prodrug
by: A. N. Tevyashova
Published: (2014-12-01) -
Preparation of Glutathione-Responsive Paclitaxel Prodrug Based on Endogenous Molecule of L-Glutathione Oxidized for Cancer Therapy
by: Xiao Duan, et al.
Published: (2024-09-01) -
A self‐reinforced activatable photosensitizer prodrug enabling synergistic photodynamic and chemotherapy
by: Daipeng Huang, et al.
Published: (2024-12-01) -
Current Trends in Clinical Trials of Prodrugs
by: Diogo Boreski, et al.
Published: (2025-02-01)